Acute kidney injury (AKI) is a frequent postoperative complication amongst liver transplant recipients and is associated with increased morbidity and mortality. This systematic review analysed the existing predictive models, in order to solidify current understanding. Articles were selected for inclusion if they described the primary development of a clinical prediction model (either an algorithm or risk score) to predict AKI post liver transplantation. The database search yielded a total of seven studies describing the primary development of a prediction model or risk score for the development of AKI following liver transplantation. The models span thirteen years of clinical research and highlight a gradual change in the definitions of AKI, emphasising the need to employ standardised definitions for subsequent studies. Collectively, the models identify a diverse range of predictive factors with several common trends. They emphasise the impact of preoperative renal dysfunction, liver disease severity and aetiology, metabolic risk factors as well as intraoperative variables including measures of haemodynamic instability and graft quality. Although several of the models address postoperative parameters, their utility in predictive modelling seems to be of questionable relevance. The common risk factors identified within this systematic review provide a minimum list of variables, which future studies should address. Research in this area would benefit from prospective, multisite studies with larger cohorts as well as the subsequent internal and external validation of predictive models. Ultimately, the ability to identify patients at high risk of post-transplant AKI may enable early intervention and perhaps prevention.
Last year, 2015, was the 30th anniversary of liver transplantation in Australia and New Zealand. We took this occasion as an opportunity to explore a well-recognised, however poorly understood, complication following liver transplantation (LT).
This systematic review focuses on the existing predictive models for acute kidney injury (AKI) following LT. It seeks to determine if there is any consensus amongst published risk models, in the hopes of enhancing current understanding. Better insight into predictors of post LT renal impairment may provide a foundation for early identification and possible interventions for prevention.
Orthotopic LT is established as an important treatment option in end-stage liver disease. It is frequently complicated by postoperative acute kidney injury 1 , with reported incidences ranging from 11%-94% [2] [3] [4] [5] [6] [7] . For LT recipients, the occurrence of AKI is strongly associated with worse outcomes, including longer intensive care unit (ICU) and hospital stays, increased postoperative infection rates, lower graft survival, higher incidence of chronic renal disease and higher mortality 2, [8] [9] [10] [11] [12] [13] . According to the 26th report of the Australian & New Zealand Liver Transplant Registry, 236 adult and 42 child LTs were performed in 2014. The incidence of AKI is not specified, but is included in the list of 'other' complications. Wyssusek et al 61 described the incidence of AKI for the population at the Princess Alexandra Hospital, one of the six Australian and New Zealand sites performing LT, to be 25%.
The development of post-transplant kidney injury appears to be multifactorial, with numerous preoperative, intraoperative and postoperative factors involved. Preexisting kidney impairment is frequent amongst patients with end-stage liver disease 14, 15 . It may be related to the primary underlying disease or develop secondarily due to the physiological changes which characterise end-stage hepatic failure (hepatorenal syndrome) 14 . In addition, LT recipients face a multitude of renal insults during the perioperative period, including intraoperative haemorrhage, postoperative sepsis, graft dysfunction and calcineurin inhibitor nephrotoxicity, which may all contribute to AKI 15, 16 . Numerous researchers have sought to delineate the role of these various risk factors and to develop predictive models for post-transplant renal impairment. Investigation into postoperative AKI has been hampered by the lack of a standard definition for AKI, with more than 30 definitions being reported within the literature 9 . These range from defining AKI as the need for renal replacement therapy (RRT) to more mild degrees of kidney injury, with a plethora of definitions based on absolute or percentage increases in serum creatinine over various time periods.
In 2004, the RIFLE (Risk, Injury, Failure, Loss of kidney function, End-stage kidney disease) criteria were published, providing a consensus definition for acute renal failure in critically ill patients 17 . The RIFLE criteria were further refined in 2007, with a modified classification system introduced by the Acute Kidney Injury Network (AKIN) 18 . Both RIFLE and AKIN have been validated as predictors of poor outcomes in multiple clinical settings 19 , including LT recipients 11, 20 . Together, the advent of RIFLE and AKIN represents a shift towards standardised definitions for AKI, which will enable better comparisons between studies and facilitate collaborative research in this area.
Many of the employed definitions for AKI rely on serum creatinine (sCr) or creatinine-based estimated GFR (eGFR) in their evaluation of renal function. However, sCr displays several shortcomings when used in the evaluation of AKI following LT. Firstly, rises in serum creatinine demonstrate a lag-time with a delay of several days after changes in GFR 21 . Thus, it may not represent the best choice for early detection of postoperative AKI. Secondly, serum creatinine is known to overestimate renal function in liver disease 16, 22 . The shortcomings of creatinine-based methods have prompted extensive research into new ways of evaluating renal function. In recent years, there has been a focus on the identification of novel biomarkers, such as Cystatin C (CyC) and neutrophil gelatinase-associated lipocalin (NGAL). Both of these biomarkers have been identified as early detectors of kidney injury when compared to creatinine-based methods [23] [24] [25] . Their use has also been validated amongst LT populations 16, 26, 27 . Research into post LT kidney injury has experienced a transformation, with evolving definitions for AKI as well as the emergence of new methods for determining renal function. It is an expanding field, with recent studies continuing to identify new independent risk factors 28 as well as the recent publication of new predictive models 29, 30 .
Methods

Study selection
A literature search was conducted using the PubMed/ MEDLINE database to identify articles which focused on acute kidney injury following liver transplantation, using the Medical Subject Headings (MeSH) and keywords "liver transplantation" (hepatic transplantation, liver grafting) and "acute kidney injury" (acute renal failure, insufficiency). The search was limited to studies published in English prior to May 2015. The citing articles and references of relevant publications were subsequently reviewed to identify any additional studies.
Articles were selected for inclusion if they described the primary development of a clinical prediction model (either an algorithm or risk score) to predict AKI post LT. Models predicting all definitions of AKI were considered. Studies were deemed ineligible if they utilised logistic regression methods without the development of a prediction rule.
Study analysis
Evaluation of the selected studies involved analysis of the study site, time period, sample size, patient demographics, exclusion criteria, definition of AKI, and reported outcome incidence, as well as a comparison of the different variables incorporated within the prediction models. Reported measures of model accuracy were recorded, including measures of calibration (e.g. the Hosmer-Lemeshow test) and discrimination (e.g. area under the receiver operating characteristic curve or AUROC). Model generalisability was evaluated and internal or external validations of the risk models were documented.
Statistics
Statistical analysis was performed using Stata/IC version 13.1 (StataCorp LP).
Results and discussion
The database search yielded an initial result of 624 references. Six studies described the primary development of a prediction model 12, [29] [30] [31] [32] [33] and one article developed a risk score for predicting AKI following liver transplantation 25 . There were no studies reporting external validation of pre-existing models.
The seven single-centre studies were published between 2002 and 2015 and encompass a total of 1818 patients (Table 1) . There were several similarities in exclusion criteria ( Table 2) .
Definitions of AKI
The seven prediction models demonstrate significant variation in the range of AKI incidence, reflecting the evolving definitions of kidney injury over the last 13 years (Table 3) .
Early models 12, 31 relied on a dichotomous definition of renal dysfunction, simply dividing patients into those who required RRT versus those who did not, although defined criteria for initiating RRT were often lacking. These studies presumably included patients experiencing milder forms of renal impairment within their non-RRT groups. The more recent models have adopted broader definitions, including more mild degrees of renal impairment rather than dialysis requirement alone. For example, AKI has been defined either as serum creatinine 133 μmol/l with an increase of 50% above the baseline level and/or the requirement for RRT 33 ; or by applying the AKIN criteria 25 or modifications to this 30 , reflecting recent recommendations for the classification of renal dysfunction in patients with cirrhosis 34 . A recent model 29 returned to a dichotomous RRT-based definition, citing the retrospective nature of their study and limitations in data collection as a driving factor behind this choice.
It has been well established that RRT-dependent AKI has a significant impact on outcomes such as mortality, both in general and within liver transplant populations 13, [35] [36] [37] . Recently, considerable attention has been given to the impact of more mild degrees of kidney injury. Numerous studies have shown that even subtle changes in serum creatinine can significantly impact patient outcomes in a variety of settings 38, 39 . The detrimental role of mild AKI (without the need for RRT) has been reinforced in liver transplant populations 2, 40 , with evidence that mild serum creatinine increases (44 μmol/l) are associated with long-term renal dysfunction as well as poorer patient and graft survival 9 . With the exception of the study conducted by Kim et al 29 , the prediction models illustrate a chronological shift towards definitions of AKI that encompass more mild degrees of renal impairment.
The prediction models also vary in the time frames in which they considered the development of AKI as outlined in Table  3 . Liver transplant recipients face numerous renal insults and have been found to develop kidney injury at various timepoints throughout the perioperative course. The study conducted by Contreras et al 12 suggests that AKI within the first seven days postoperatively is primarily a function of preoperative parameters (specifically pre-transplant renal function). In contrast, they found that development of late AKI (after seven days) was unrelated to preoperative renal function, and instead, was associated with intraoperative blood product requirement and APSIII score (an acute physiology score with weightings derived from the APACHE III prognostic model). Differentiation between immediate and late postoperative AKI is supported by current literature, with several studies suggesting that they may represent separate clinical entities, with distinct aetiological factors 41, 42 . This highlights the importance of considering time frame when analysing the emergence of renal dysfunction in the post-transplant setting. It suggests that there may be theoretical difficulties when comparing studies that address different follow-up periods. Time frame is an essential aspect in any study's definition of AKI.
Trends in identified predictive factors
Despite the variation in their employed definitions of AKI, the seven predictive models demonstrate commonalities in their identified predictive factors (Table 4) . Generally the models discriminate well (Table 5) . 12 derived a prediction model based solely on preoperative blood urea nitrogen (BUN), preoperative serum creatinine (sCr) and preoperative urine output. Their study found that there was little improvement in model performance with the addition of other preoperative and intraoperative variables and they concluded that the requirement for RRT posttransplant was primarily influenced by pre-transplant renal dysfunction. Similarly, Xu et al 33 incorporated preoperative sCr (>106 μmol/l), and the Sanchez et al model 31 included both preoperative sCr (>168 μmol/l) and preoperative BUN (10 mmol/l).
Preoperative renal dysfunction
The concept that preoperative renal impairment plays an important role in the development of post-transplant AKI has been repeatedly demonstrated in existing literature, with particular attention given to pre-transplant serum creatinine as an independent risk factor 5, 6, [43] [44] [45] [46] . However, it is noteworthy that Rueggeberg et al 32 , Portal et al 25 , Kim et al 29 and Hilmi et al 30 did not include any surrogates for preoperative renal function within their final predictive models. These articles illustrate an important contrast to the Contreras et al model 12 , which was derived exclusively from measures of preoperative renal impairment.
The inclusion of sCr, BUN and preoperative urine output within the Contreras et al model 12 raises an interesting discussion point. The incorporation of all three variables implies mutual independence between these parameters. Serum Cr and BUN are typically viewed as surrogates for glomerular filtration, whereas preoperative urine output is considered predictive of the ability to handle a fluid load 12 .
The authors have hypothesised that the apparent independence may arise due to physiological factors associated with end-stage liver disease, which impact the accuracy of sCr and BUN. Patients with hepatic failure typically demonstrate misleadingly low serum creatinine levels due to malnutrition, reduced muscle mass and decreased creatinine biosynthesis 6, 43 . On the other hand, BUN may be either artificially elevated (due to gastrointestinal bleeding or increased catabolism) or reduced (due to low dietary protein intake and impaired hepatic synthetic function) 6 . These inaccuracies complicate the use of sCr and BUN as surrogates for renal function in patients with liver disease and may contribute to their emergence as independently significant predictors in the Contreras et al study 12 .
The concept that pre-existing renal dysfunction is the sole predictor is intuitively simplistic. Several recent articles have focused on kidney injury following liver transplantation in patients with normal preoperative renal function 8, 11 . They demonstrate that post-transplant renal impairment occurs frequently even amongst patients with a normal baseline renal status. In addition, they show that there are other identifiable risk factors for AKI even when the variable of preoperative renal impairment is eliminated.
Liver disease severity
Liver disease severity has been identified as a potential predictor for postoperative kidney injury. Both Sanchez et al 31 and Kim et al 29 included the Model for End-Stage Liver Disease (MELD) score as a variable in their clinical prediction models. Xu et al 33 also showed that MELD score >25 was significantly associated with a high risk of AKI but it was not retained as an independent predictor after multivariate analysis. The MELD score functions as a disease severity index, derived from serum creatinine, bilirubin and International Normalized Ratio. It has been validated as a predictor of three-month mortality amongst patients on liver transplantation waiting lists and has subsequently been adopted by the United Network for Organ Sharing (UNOS) as a method of organ allocation 47, 48 . Several previous studies have supported the role of MELD score as an independent predictor for post-transplant AKI 8, 20, 49 . Although Hilmi et al 30 found that MELD score was not a significant risk factor, their final predictive model incorporated Child-Pugh score, a tool to assess prognosis of liver disease. The importance of disease severity is further reflected by the inclusion of hepatic encephalopathy within the Kim et al predictive model 29 . In fact, the authors note that hepatic encephalopathy had the highest odds ratio as a predictor for RRT [OR = 5.47 (1.93-15.52), P=0.001].
To some extent, the observed association between liver disease severity and postoperative AKI may simply reflect the interrelationship between hepatic and renal function in cirrhotic patients 49 . Patients with more advanced liver disease experience a higher incidence of pre-existing kidney impairment, which may underlie the development of postoperative AKI within this patient group. MELD score is highly weighted for serum creatinine and thus encompasses an element of poorer renal function within its representation of liver disease severity 48 .
Liver disease aetiology
Liver disease aetiology has been implicated as a potential predictor of postoperative renal impairment in some studies. Rueggeberg 29 studies all indicated that hepatitis B and hepatitis C infection had no significant impact on the incidence of postoperative AKI. However, the Kim et al study 29 did implicate liver disease aetiology in another way. They showed that hepatocellular carcinoma (HCC) was a protective factor. It was associated with a decreased incidence of postoperative RRT requirement and was retained in their final risk model. The authors postulated that this may have occurred due to differences in organ allocation in cases of malignancy. They argued that the use of the Milan criteria as a selection process for patients with cirrhosis and HCC may lead to lower MELD scores amongst this cohort. This therefore suggests that the protective nature of HCC may possibly reflect a selection bias for lower disease severity in these patients rather than an intrinsic property of the disease process itself.
Metabolic risk factors
The seven published models provide some insight into the potential predictive role of metabolic risk factors such as pre-existing diabetes mellitus and obesity. Firstly, Hilmi et al 30 included pre-transplant diabetes as a risk factor in their prediction model. This finding is reflected in the current literature, with some studies showing that pre-existing diabetes is associated with higher risk of immediate AKI 50,51 as well as long-term chronic kidney disease (CKD) following liver transplantation 4, 52 . Diabetes is well established as a risk factor for CKD in the general population 4, 53 and its role in posttransplant AKI may reflect pre-existing end-organ damage. However, in contrast, Rueggeberg et al 32 demonstrated that preoperative diabetes did not increase the incidence of posttransplant AKI (RR = 1.0).
The potential significance of metabolic risk factors is also highlighted by the inclusion of weight (>100 kg) as a 54, 55 . The predictive effect of increased preoperative weight on post-transplant AKI may simply reflect increased liver disease severity and/or renal dysfunction.
Haemodynamic status
Another prominent concept discussed within the seven models is the predictive role of the haemodynamic status. Rueggeberg et al 32 found that arterial hypertension pretransplant, lower mean arterial pressure (MAP) at the time of anaesthetic induction, increased intraoperative packed red blood cell (PRBC) requirement and intraoperative hypotension (MAP <50 mm Hg) were all predictive of renal impairment. The authors concluded that haemodynamic instability was a fundamental factor in the development of post-transplant kidney injury. These findings were reflected by the Xu et al model 33 , which incorporated intraoperative hypotension and low intraoperative urine output as well as the Kim et al model 29 which included intraoperative blood loss (in litres). Haemodynamic instability is frequently encountered in the course of liver transplantation 11 . It is the product of multiple factors, including blood loss due to haemorrhage from surgical procedures, coagulation disturbances and hypotension after graft reperfusion 6, 33 . The contribution of haemodynamic instability to postoperative renal injury is well supported in the existing literature 2, 6, 11, 43, 44, 56 . It is interesting that Rueggeberg et al 32 identified preoperative hypertension as a risk factor. The authors argue that patients with preoperative hypertension could experience a more marked variation in blood pressure, with a greater difference between their baseline and intraoperative measurements. Furthermore, hypertension is a recognised feature of chronic kidney disease 3 . Thus, it is possible that preoperative arterial hypertension also reflects more advanced pre-existing renal impairment, which is in itself a potential risk factor for post-transplant renal dysfunction.
Xu et al 33 demonstrated that intraoperative use of noradrenaline served as a protective factor and was associated with a reduced incidence of AKI. The authors cited clinical and animal studies and suggested that noradrenaline may actually improve renal blood flow in vasodilated states 57, 58 . These findings are in contrast to several previous studies, which identified increased vasopressor requirement as a risk factor for post-transplant renal failure 3, 11, 45, 46, 56 . Unlike Xu et al 33 , they argue that increased vasopressor requirement reflects greater haemodynamic instability with likely associated renal hypoperfusion. Traditionally, vasopressors are believed to constrict the renal vasculature and decrease renal blood flow 11, 46 . The work of Xu et al 33 highlights the need for further studies in order to fully delineate the role of vasopressors, such as noradrenaline in particular. Despite this apparent controversy, both Rueggeberg et al 32 and Xu et al 33 emphasise the impact of haemodynamic status as a predictive factor for post-transplant renal impairment.
Graft quality
There is some evidence to suggest that graft characteristics may influence the development of postoperative renal impairment. For example, Kim et al 29 demonstrated that use of deceased donor liver transplants (DDLT) was significantly associated with increased postoperative RRT requirement (P <0.001) and included it as a predictive variable. They proposed that this may occur due to lower MELD scores in living donor liver transplant (LDLT) recipients as well as 29 , they found that there was no significant difference in rates of postoperative AKI between living vs. cadaveric grafts (RR = 1.0).
Organ failure scores
The models also explore the possible use of various organ failure scores in predicting post-transplant renal dysfunction. In the Portal et al study 25 , both the Sequential Organ Failure Assessment (SOFA) score and the Acute Physiology and Chronic Health Evaluation II (APACHE II) score were associated with the development of post-transplant AKI. However, only the APACHE II score was retained as an independent predictor and ultimately included in the Portal et al algorithm 25 . Similarly, the Contreras et al model 12 incorporated APSIII score. Both the APACHE II and APSIII scores require collection of physiological data during the first 24 hours following ICU admission, therefore delaying the implementation of any prediction model.
Other postoperative risk factors
Several other postoperative variables were utilised within the seven published risk models. Portal et al 25 measured plasma NGAL (pNGAL) levels within the first 12 hours after transplantation and included pNGAL >258 ng/ml in their renal risk score. NGAL is considered to be a marker of kidney injury, and shows a rapid rise that may occur up to 48 hours before any associated increase in serum creatinine 24, 25 . Therefore, NGAL may be best described as an early indicator that kidney injury has already occurred rather than a risk factor for future renal dysfunction.
The Sanchez et al 31 model included 'postoperative ICU stay >3 days' as a predictive variable, effectively preventing risk stratification any earlier than the third postoperative day. It is possible that this variable represents a consequence of AKI rather than a predictor for its development. Rueggeberg et al 32 indicate that by day three, 43% of their AKI patients were already requiring RRT. Xu et al 33 showed a similar trend, with median time for development of AKI being two days. Although some postoperative factors may show strong statistical relationships with post-transplant renal dysfunction, their inclusion in prediction models may minimise options for intervention and prevention.
Other contributing factors
The analysed models display several commonalities, highlighting the predictive role of preoperative renal dysfunction, liver disease severity and aetiology, metabolic risk factors as well as intraoperative haemodynamic status and graft quality.
Numerous studies have further explored independent risk factors that have not been identified as predictive variables within any of the seven published risk models. Weber et al 22 analysed the spectrum of renal dysfunction pre-, during-and post-transplantation, contributing to the development of AKI after LT. The factors included are: haemodynamic-related GFR decline, hepatorenal syndrome, pre-existing kidney disease, parenchymal renal disease associated with liver disease, acute tubular necrosis, and calcineurin inhibitors. Hilmi Several classifications of risk factors have been suggested including pre-, intra-and post-transplantation or early and late predictors.
We suggest that future studies could concentrate on factors that can be modified by clinicians and those that are predetermined as both may offer different possible therapeutic interventions. Patient factors defined as preexisting organ dysfunction may be of predictive value whereas factors within some control by the clinicians such as use of fluids, vasopressors and blood products may be of value for prevention.
Validation of the predictive models:
Several complementary tests are used to assess the performance of a predictive model. 25 included discussion of a separate validation cohort. There have been no independent studies publishing external validations for any of the seven existing models. None of the studies included a discussion of the impact of their model in the clinical setting (Table 6 ).
Future directions, research implications and clinical implications
Predictive modelling for postoperative kidney injury is relevant to many surgical subspecialties and has been explored within other fields. A recent systematic review by Huen et al 60 evaluated the existing risk models for AKI following cardiac surgery. In contrast to the work within the LT community, it revealed a small number of multicentre and multinational studies with larger cohorts and several external validations of the established models. Ultimately, this suggests that research into AKI following LT is perhaps lagging behind the cardiothoracic field.
Future research must clearly define the target population, provide a consistent definition for AKI, agree on the data to be collected and outcomes that are assessed and consider the place of collection and possible "banking" of biological samples. Target interventions for evaluation may be process of care, risk factor modification, specific therapeutic options and AKI treatment modalities. Clinical trial methodology continues to evolve and adaptive clinical trials and factorial design can facilitate efficient testing of the effectiveness of a raft of interventions that each target different biological aspects of a disease.
Defining AKI in clinical practice continues to evolve. Debate continues on the clinical utility of various classification systems and definitions. The RIFLE 17 criteria were modified by AKIN 18 to provide diagnostic criteria. More recently the Kidney Disease Improving Global Outcomes group has proposed additional suggestions in an effort to harmonise the various definitions that exist 62 . These criteria provide options of absolute or relative rises in creatinine or a reduction in urine output and provide guidance on the time frame of these changes to meet the definition of AKI.
Conclusions
The seven published predictive models for acute kidney injury following liver transplantation span 13 years of research and address a diverse range of AKI definitions. They highlight a gradual shift towards including more mild degrees of renal impairment and reinforce the need to employ standardised definitions within future research.
Together, the models demonstrate several commonalities such as preoperative renal dysfunction, intraoperative haemodynamic instability, underlying liver disease and organ failure scores in identified predictive variables, providing a benchmark for subsequent investigations. Direct comparison between models is hindered by small cohorts as well as disparity in the definitions of AKI and the various follow-up time frames applied. Future studies into postoperative AKI following LT, should at a minimum, address variables such as preoperative renal impairment, liver disease severity and aetiology and metabolic risk factors as well as intraoperative variables including measures of haemodynamic instability and graft quality.
Although the existing models demonstrate the possible utility of various postoperative parameters, their inclusion is likely to be of little relevance as the clinical use of any risk model is dependent on its ability to adequately predict an outcome in a time frame that allows for intervention. Future studies may benefit from inclusion of novel biomarkers, which allow for early identification of AKI. Ultimately, the seven existing models reinforce the need for prospective, multi-site studies with larger cohorts and the subsequent external validation of the existing algorithms.
